ABSTRACT Introduction The Global Initiative for Chronic Obstructive Lung Disease (GOLD)
strategy report provides guidance on effective management of chronic obstructive …

BACKGROUND: According to the GOLD international guidelines, the treatment of chronic
obstructive pulmonary disease (COPD) should be proportional to the severity of airflow …

Inhaled corticosteroids (ICS) have had an important impact on the management of chronic
obstructive pulmonary disease (COPD). When combined with an inhaled long-acting b …

Extract The opinion piece by Celli and Vestbo [1] proposing a simple algorithm for
pharmacotherapy of patients with COPD, especially regarding inhaled corticosteroids (ICS) …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, which is
characterised by reduced post-bronchodilator lung function in all patients [1]. Although …

Extract We have read the comments made by S. Suissa regarding the algorithm for COPD
therapy that we recently proposed in our editorial viewpoint in the European Respiratory …

Background Chronic obstructive pulmonary disease (COPD) is common around the world
and carries a high morbidity and mortality. Symptom-and risk-oriented drug treatment is …

The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. In published
RCTs, ICS could be withdrawn in COPD patients without increasing exacerbation risk when …

Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Inhaled corticosteroids (ICS) are the mainstay of treatment for asthma, but their role in
chronic obstructive pulmonary disease (COPD) is debated. Recent randomised controlled …